About this sample. This page shows the method and structure of the report. It contains no client data; every engagement is prepared for the specific study and indication.
1Overview
A transparent view of the commercial opportunity for an indication or product. Population, treatment and price inputs are assembled with their sources and grades, and combined into scenario ranges. Outputs are scenarios, not forecasts, and every assumption is labelled.
2Questions this report answers
- ?How many patients are eligible for treatment, and how many are treated?
- ?Which dose and price inputs apply, and how reliable are they?
- ?How sensitive is the opportunity to uptake, price and persistence?
- ?Which inputs are confirmed and which are assumptions?
3Protocol
The report follows the same documented sequence for every study. Each step produces an output that is kept in the final report.
- 1
Segment definition
The indication, patient segment and geography are defined together with the product profile.
Output: Segment definition
- 2
Eligible population
Prevalence is applied to official population estimates by age and state to size the eligible population.
Output: Population table
- 3
Treatment inputs
Treated share and dosing are taken from published guidance and labelled as assumptions where they are not observed.
Output: Treatment inputs
- 4
Price inputs
Pharmacy acquisition cost and list price data are collected, with their dates and units normalised.
Output: Price inputs
- 5
Scenario model
Population, treatment and price are combined into low, base and high scenarios.
Output: Scenario model
- 6
Sensitivity and walkthrough
The inputs with the greatest effect are identified and reviewed with your team.
Output: Report and session
4Report contents
| Section | Title | What it contains |
|---|---|---|
| 1 | Executive summaryScenario range and the inputs that matter most. | Scenario range and the inputs that matter most. |
| 2 | PopulationEligible and treated population by segment. | Eligible and treated population by segment. |
| 3 | Treatment and doseInputs with their source and grade. | Inputs with their source and grade. |
| 4 | PricingPharmacy cost and list price inputs. | Pharmacy cost and list price inputs. |
| 5 | ScenariosLow, base and high opportunity ranges. | Low, base and high opportunity ranges. |
| 6 | SensitivityHow each input changes the result. | How each input changes the result. |
5Evidence standards
Every figure in the report carries its source, its date and one of four evidence grades, so you can see what is confirmed and what is assumed.
Confirmed
Reported directly by an authoritative source.
Documented
Published or documented, with a clear method.
Estimated
Derived by Clinovia from graded inputs.
Assumed
An explicit assumption, open to review.
6Inputs and deliverables
What we need from you
- Product profile and target segment
- Geography of interest
- Pricing assumptions, optional
What you receive
- Written report (PDF)
- Scenario model (Excel)
- Walkthrough session with your team
Discuss this report for your study
Tell us about the indication and the decision in front of you. A pilot on a single study is a good place to start.
Other intelligence reports